Tag: Brexit Impact
-
UK Must Heed Sir John Bell’s Pharma Investment Warning
Understanding the Stakes: Sir John Bell’s Warning Sir John Bell, a prominent figure in the UK’s biotechnology sector, has raised significant concerns over the pharmaceutical industry’s future in the UK. His recent caution follows the announcement that US pharmaceutical giant Merck is scrapping its ambitious £1 billion research center planned for King’s Cross, London. This…
-
Merck Scraps £1 Billion UK Expansion Over Investment Concerns
Overview of Merck’s Decision In a significant blow to the UK pharmaceutical sector, US pharmaceutical giant Merck has announced it will scrap a planned £1 billion expansion of its operations in the United Kingdom. This decision stems from the company’s frustrations regarding insufficient governmental support and investment. As a major player in the global pharmaceutical…